Skip to main content

Chibougamau Updates Agreement with TomaGold

ROUYN-NORANDA, Quebec , Sept. 30, 2025 (GLOBE NEWSWIRE) — Chibougamau Independent Mines Inc. (CBG-TSX-V in Canada, CLL1-Frankfurt, Stuttgart, Berlin and Lang & Schwarz Stock Exchanges in Germany, CMAUF-OTC in the US), herein called Chibougamau, wishes to inform shareholders that it has amended its agreement with TomaGold Corp. wherein TomaGold has the opportunity of acquiring, under an option, 100% interest in Chibougamau’s Berrigan South, Berrigan Mine, Antoinette, Elaine Lake and Gwillim properties northwest of the Town of Chibougamau, Quebec. Consideration under the updated agreement now stands at:$2,700,000 in cash payments, of which $300,000 has been completed, and the balance to be paid as follows: (i) $50,000 upon receipt of the TSXV approval; (ii) $150,000 no later than December 31, 2025 (the “Second Anniversary”);...

Continue reading

Terra Innovatum and GSR III Acquisition Corp. Remind Shareholders to Vote and Approve the Business Combination Prior to the October 7 Extraordinary General Meeting of Shareholders

GSRT shareholders are encouraged to use their voice and vote FOR the business combination and other proposals ahead of the deadline on October 6, 2025, at 11:59 p.m. ET Shareholders as of September 15, 2025, should vote their shares even if they no longer own themNEW YORK and AUSTIN, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) — Terra Innovatum Srl (“Terra Innovatum” or the “Company”), a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (“GSRT”) (Nasdaq: GSRT), a publicly traded special purpose acquisition company, remind GSRT shareholders to vote “FOR” their proposed business combination and all other proposals detailed in the definitive proxy statement/prospectus (the “Proxy Statement”). Shareholder Meeting Details GSR III Acquisition Corp. will hold its...

Continue reading

Karbon Acquires Aider to Deliver the Future of AI-Powered Accounting and Bookkeeping

The acquisition brings automation and AI insights to help firms close books faster, cut workloads, and focus on higher-value client work. SAN FRANCISCO, Sept. 30, 2025 (GLOBE NEWSWIRE) — Karbon, the global leader in practice management software for accounting, bookkeeping, tax and audit firms, today announced its acquisition of Aider, a pioneer in AI-powered advisory and reporting technology. The acquisition accelerates Karbon’s vision to transform the accounting profession through AI. Aider’s cutting-edge solution is already trusted by firms across the United States, Canada, Australia, and New Zealand for automating time-consuming bookkeeping and advisory workflows like reconciliations and period close, while delivering real-time client insights and predictive reporting. By integrating Aider’s capabilities into Karbon, firms will...

Continue reading

Alpine Testing Solutions Inc. Acquired by Volaris Group

Volaris enters Workforce Management vertical TORONTO, Sept. 30, 2025 (GLOBE NEWSWIRE) — Volaris Group today announced the acquisition of Alpine Testing Solutions Inc., a leader in psychometric consulting and test security services for credentialing and licensure programs. Founded in 1991 and based in Orem, Utah, Alpine Testing Solutions Inc. provides expertise and solutions to help organizations create and maintain high-quality assessment programs that are fair, reliable, and defensible. “Alpine Testing Solutions Inc. has built a trusted reputation in professional certification, helping organizations worldwide uphold the integrity and value of their credentialing programs,” says Mike Borello, Group Leader, Volaris Group. “We are proud to welcome Alpine into Volaris Group and to support their next chapter of growth with a permanent...

Continue reading

Barinthus Biotherapeutics to Combine with Clywedog Therapeutics to Target Metabolic and Autoimmune Diseases

The combined company, Clywedog Therapeutics, will bring a portfolio that includes three differentiated, clinical stage product candidates which are being studied for the prevention/reversal of Type 1 and Type 2 Diabetes and the treatment of Celiac Disease.Four key value-driving milestones are expected within 18 months, including clinical proof of concept in multiple indications. Estimated cash runway for combined company extends through 2027.Transaction projected to close in the first half of 2026. The combined company will be backed by OrbiMed and Torrey Pines and is expected to trade under the NASDAQ symbol “CLYD.”GERMANTOWN, Md. and ALTRINCHAM, United Kingdom, Sept. 30, 2025 (GLOBE NEWSWIRE) — Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”), an immunology and inflammation company focused on developing therapies...

Continue reading

Stella-Jones Expands its Utility Product Offering with an Agreement to Acquire Brooks Manufacturing Co.

Strategic acquisition adds complementary products to broaden market reach and accelerate growth MONTREAL, Sept. 30, 2025 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX: SJ) (“Stella-Jones” or “the Company”) announced today that it has entered into a definitive agreement to acquire the assets of Brooks Manufacturing Co. (“Brooks”), a manufacturer of treated wood distribution crossarms and transmission framing components located in the United States. This transaction marks another significant step in the Company’s strategy to expand beyond its traditional product categories and leverage its extensive sales and distribution network to better support the needs of the utility sector. Founded in 1915, Brooks is a long-standing supplier to utilities with a proven track record of quality and customer service. It operates a facility located...

Continue reading

Notification on obligation to make a mandatory tender offer

Copenhagen Airports A/S hereby announces, that it has, today, received the attached notification from The Kingdom of Denmark via the Ministry of Finance. As stated in the notification, the Ministry of Finance, has acquired a controlling shareholding in Copenhagen Airports A/S and is obliged to, no later than 4 weeks from today, make a mandatory tender offer to the remaining shareholders of Copenhagen Airports A/S, pursuant to Section 45 of Consolidated Act no. 652 of 10 June 2025 on Capital Markets, as amended, and Section 3(1) of Executive Order no. 614 of 2 June 2025 on Takeover Bids.COPENHAGEN AIRPORTS A/S P.O. Box 74 Lufthavnsboulevarden 6 DK-2770 KastrupContact: Lars Nørby Johansen Chairman of the Board of DirectorsTelephone: +45 32312800 E-mail: cphpresse@cph.dk www.cph.dk CVR no. 14 70 72 04AttachmentSection...

Continue reading

Market-leading Australian investor administration and services platform Automic Group acquired by Advent

Photo Courtesy of Automic Group SYDNEY, Sept. 30, 2025 (GLOBE NEWSWIRE) — Market-leading Australian investor administration and services platform Automic Group today announced that leading global private equity investor Advent will acquire the business. Through its purpose-built, cloud-native technology platform, Automic has transformed investor services to streamline and simplify shareholder management, fund administration, share plans, reporting and analytics for listed and unlisted companies, investment funds, wealth advisors and investors. The high-growth Automic business will be acquired from the Group’s founding investors, the ADBO Group, and other shareholders, including Five V Capital and Automic team members with equity in the business. Automic supports more than 1,400 companies and funds across Australia and New Zealand,...

Continue reading

SciSparc: N2OFF Shareholders Approve Merger with SciSparc’s Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer

TEL AVIV, Israel, Sept. 29, 2025 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that on September 25, 2025, the stockholders of N2OFF, Inc. (NASDAQ: NITO) (“N2OFF”) voted on and approved, among other things, the proposed acquisition of SciSparc’s majority owned subsidiary, MitoCareX Bio Ltd. (“MitoCareX”). This important milestone, achieved at N2OFF’s special meeting of stockholders held on September 25, 2025, clears a key path for the completion of the Acquisition, which would result in MitoCareX becoming a wholly owned subsidiary of N2OFF. MitoCareX is focusing on the development of novel therapies for hard-to-treat...

Continue reading

Critical Metals Corp Amends Agreement to Acquire a Controlling Interest in Tanbreez

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) — Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, today announced that it has amended its agreement to acquire the Tanbreez Greenland Rare Earth Mine (the “Tanbreez Project”) from Rimbal Pty Ltd. (“Rimbal”), a company controlled by geologist and project founder Gregory Barnes. Under the terms of the amended agreement, Critical Metals Corp now has the right to increase its ownership stake in the Tanbreez Project from 42% to 92.5% upon the issuance of approximately 14.5 million ordinary shares of the Company to Rimbal. Under the original agreement, the consideration for this increase in ownership was an unspecified number of shares of Critical Metals Corp with a value of $116 million determined at the time of the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.